Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tcf21
|
ENSMUSG00000045680.7 | transcription factor 21 |
Msc
|
ENSMUSG00000025930.5 | musculin |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_14770681_14770832 | Msc | 14764 | 0.169083 | 0.28 | 4.2e-02 | Click! |
chr10_22820110_22820281 | Tcf21 | 21 | 0.972758 | 0.58 | 4.1e-06 | Click! |
chr10_22819776_22820046 | Tcf21 | 248 | 0.907486 | 0.49 | 1.5e-04 | Click! |
chr10_22818077_22818228 | Tcf21 | 2007 | 0.256073 | 0.35 | 8.6e-03 | Click! |
chr10_22868522_22868942 | Tcf21 | 48558 | 0.119280 | 0.33 | 1.5e-02 | Click! |
chr10_22821813_22821964 | Tcf21 | 1714 | 0.320436 | 0.27 | 4.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_98743854_98744203 | 31.16 |
Fkbp11 |
FK506 binding protein 11 |
15830 |
0.09 |
chr6_91549627_91549803 | 17.51 |
Gm45216 |
predicted gene 45216 |
27306 |
0.1 |
chr2_74956047_74956226 | 16.65 |
n-R5s198 |
nuclear encoded rRNA 5S 198 |
20622 |
0.17 |
chr2_74955838_74956008 | 14.95 |
n-R5s198 |
nuclear encoded rRNA 5S 198 |
20409 |
0.17 |
chr15_68176469_68176706 | 14.52 |
Zfat |
zinc finger and AT hook domain containing |
82200 |
0.09 |
chr10_115774542_115774739 | 14.21 |
Tspan8 |
tetraspanin 8 |
42192 |
0.18 |
chr18_14331694_14332025 | 13.58 |
Gm50097 |
predicted gene, 50097 |
2 |
0.7 |
chr15_80253610_80253775 | 13.38 |
Atf4 |
activating transcription factor 4 |
1492 |
0.25 |
chr1_135731863_135732606 | 13.07 |
Csrp1 |
cysteine and glycine-rich protein 1 |
3087 |
0.22 |
chr7_118478749_118479078 | 12.91 |
Gm44652 |
predicted gene 44652 |
1582 |
0.33 |
chr8_61908569_61908914 | 11.87 |
4930512H18Rik |
RIKEN cDNA 4930512H18 gene |
4319 |
0.19 |
chr5_119811188_119811362 | 11.66 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
3406 |
0.22 |
chr15_10940268_10940456 | 11.56 |
Gm49068 |
predicted gene, 49068 |
2240 |
0.25 |
chr18_52613737_52614197 | 11.21 |
Zfp474 |
zinc finger protein 474 |
1948 |
0.35 |
chr5_29826796_29827181 | 10.83 |
Gm1969 |
predicted gene 1969 |
6319 |
0.16 |
chr3_37128257_37128628 | 10.70 |
Il2 |
interleukin 2 |
2483 |
0.19 |
chr12_79856612_79856969 | 10.54 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
67943 |
0.11 |
chr10_125785483_125786054 | 10.44 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
180400 |
0.03 |
chr17_73054285_73054448 | 10.38 |
Gm30420 |
predicted gene, 30420 |
25288 |
0.19 |
chr19_55194614_55194797 | 10.22 |
Mir6715 |
microRNA 6715 |
2027 |
0.27 |
chr16_90706305_90706649 | 10.16 |
Mis18a |
MIS18 kinetochore protein A |
20662 |
0.13 |
chr18_69666395_69666944 | 10.10 |
Tcf4 |
transcription factor 4 |
10002 |
0.29 |
chr6_4489464_4489686 | 10.02 |
Gm37883 |
predicted gene, 37883 |
5377 |
0.17 |
chr1_162017014_162017390 | 9.93 |
2810442N19Rik |
RIKEN cDNA 2810442N19 gene |
12030 |
0.15 |
chr7_66872027_66872377 | 9.79 |
Adamts17 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17 |
22495 |
0.2 |
chr13_53262691_53263037 | 9.74 |
Ror2 |
receptor tyrosine kinase-like orphan receptor 2 |
12794 |
0.26 |
chr14_68934600_68935507 | 9.67 |
Gm47256 |
predicted gene, 47256 |
60218 |
0.12 |
chr11_50635067_50635596 | 9.55 |
Gm12198 |
predicted gene 12198 |
32883 |
0.14 |
chr12_79476778_79476950 | 9.43 |
Rad51b |
RAD51 paralog B |
149511 |
0.04 |
chr2_48494071_48494538 | 9.35 |
Gm13481 |
predicted gene 13481 |
37059 |
0.2 |
chr17_4199737_4199914 | 9.34 |
4930548J01Rik |
RIKEN cDNA 4930548J01 gene |
77712 |
0.12 |
chr11_6481678_6482001 | 9.32 |
Purb |
purine rich element binding protein B |
5922 |
0.08 |
chr16_93808033_93808481 | 9.19 |
Dop1b |
DOP1 leucine zipper like protein B |
1177 |
0.39 |
chr12_102302974_102303351 | 9.19 |
Rin3 |
Ras and Rab interactor 3 |
19521 |
0.2 |
chr10_93688942_93689121 | 9.17 |
Gm15915 |
predicted gene 15915 |
5709 |
0.15 |
chr2_22587496_22588353 | 9.15 |
Gm13341 |
predicted gene 13341 |
38 |
0.95 |
chr9_121589562_121589713 | 9.05 |
Lyzl4os |
lysozyme-like 4, opposite strand |
2617 |
0.21 |
chr15_62934546_62934877 | 9.03 |
Tsg101-ps |
tumor susceptibility gene 101, pseudogene |
45937 |
0.19 |
chr9_37053874_37054617 | 9.03 |
n-R5s82 |
nuclear encoded rRNA 5S 82 |
27846 |
0.12 |
chr1_189619014_189619289 | 8.99 |
Gm38122 |
predicted gene, 38122 |
21083 |
0.19 |
chr7_71368532_71368868 | 8.99 |
Gm29328 |
predicted gene 29328 |
133 |
0.96 |
chr8_92252752_92252908 | 8.96 |
Gm45334 |
predicted gene 45334 |
19705 |
0.19 |
chr17_33504087_33504456 | 8.89 |
Adamts10 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 10 |
19933 |
0.13 |
chr9_71874816_71875171 | 8.87 |
Tcf12 |
transcription factor 12 |
9718 |
0.12 |
chr2_12325362_12325810 | 8.79 |
Itga8 |
integrin alpha 8 |
23664 |
0.13 |
chr4_109460528_109460711 | 8.77 |
Rnf11 |
ring finger protein 11 |
16056 |
0.16 |
chr6_121081822_121082078 | 8.70 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
341 |
0.86 |
chr5_148569453_148569748 | 8.69 |
1700013A02Rik |
RIKEN cDNA 1700013A02 gene |
15739 |
0.17 |
chr18_62044092_62044268 | 8.63 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
66221 |
0.1 |
chr13_49581836_49581987 | 8.55 |
Omd |
osteomodulin |
551 |
0.71 |
chr14_48050113_48050425 | 8.52 |
Gm49306 |
predicted gene, 49306 |
3258 |
0.2 |
chr1_151863246_151863409 | 8.42 |
Gm25279 |
predicted gene, 25279 |
8372 |
0.2 |
chr13_73887462_73887897 | 8.38 |
Trip13 |
thyroid hormone receptor interactor 13 |
33535 |
0.1 |
chr13_26324614_26324945 | 8.37 |
1700092E19Rik |
RIKEN cDNA 1700092E19 gene |
12373 |
0.24 |
chr8_103808679_103808882 | 8.36 |
4933400L20Rik |
RIKEN cDNA 4933400L20 gene |
204981 |
0.02 |
chr11_75813147_75813298 | 8.34 |
Doc2b |
double C2, beta |
17173 |
0.15 |
chr11_60896036_60896200 | 8.34 |
Tmem11 |
transmembrane protein 11 |
16846 |
0.11 |
chr2_118461814_118462159 | 8.33 |
Eif2ak4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
4826 |
0.18 |
chr1_14795112_14795472 | 8.29 |
Gm37412 |
predicted gene, 37412 |
6647 |
0.2 |
chr9_32646586_32646900 | 8.28 |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
10495 |
0.16 |
chr1_87205559_87205833 | 8.25 |
Chrng |
cholinergic receptor, nicotinic, gamma polypeptide |
114 |
0.93 |
chr19_56545156_56545320 | 8.24 |
Dclre1a |
DNA cross-link repair 1A |
1917 |
0.31 |
chr11_103003344_103003541 | 8.21 |
Mir6931 |
microRNA 6931 |
3521 |
0.15 |
chr7_34459933_34460084 | 8.18 |
Gm12766 |
predicted gene 12766 |
21871 |
0.13 |
chr10_70967056_70967212 | 8.14 |
Bicc1 |
BicC family RNA binding protein 1 |
18645 |
0.15 |
chr5_122621646_122621889 | 8.14 |
Ift81 |
intraflagellar transport 81 |
7249 |
0.13 |
chr9_69470986_69471190 | 8.12 |
Anxa2 |
annexin A2 |
7377 |
0.13 |
chr7_107567042_107567677 | 8.10 |
Olfml1 |
olfactomedin-like 1 |
87 |
0.96 |
chr2_60688910_60689539 | 8.10 |
Itgb6 |
integrin beta 6 |
15470 |
0.23 |
chr10_87880365_87880623 | 8.09 |
Igf1os |
insulin-like growth factor 1, opposite strand |
17113 |
0.18 |
chr2_14137016_14137194 | 8.08 |
Stam |
signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 |
2983 |
0.21 |
chr1_106065887_106066056 | 8.07 |
Gm37372 |
predicted gene, 37372 |
9923 |
0.17 |
chr4_156059768_156060161 | 8.07 |
Gm13648 |
predicted gene 13648 |
162 |
0.77 |
chr1_72309841_72310010 | 8.04 |
Xrcc5 |
X-ray repair complementing defective repair in Chinese hamster cells 5 |
2498 |
0.23 |
chr1_152549139_152549347 | 8.02 |
Rgl1 |
ral guanine nucleotide dissociation stimulator,-like 1 |
3801 |
0.31 |
chr2_144769586_144769829 | 8.00 |
Gm11743 |
predicted gene 11743 |
13378 |
0.2 |
chr14_72447793_72447944 | 8.00 |
Gm9195 |
predicted gene 9195 |
43970 |
0.17 |
chr7_66529000_66529164 | 7.95 |
Gm44754 |
predicted gene 44754 |
36543 |
0.13 |
chr10_38916076_38916383 | 7.88 |
Gm17779 |
predicted gene, 17779 |
12060 |
0.24 |
chr17_67996164_67996351 | 7.81 |
Arhgap28 |
Rho GTPase activating protein 28 |
7863 |
0.29 |
chr1_78338230_78338449 | 7.79 |
Gm28410 |
predicted gene 28410 |
1767 |
0.35 |
chr11_34166622_34166773 | 7.76 |
Gm12121 |
predicted gene 12121 |
24870 |
0.17 |
chr19_44904292_44904682 | 7.71 |
Slf2 |
SMC5-SMC6 complex localization factor 2 |
26664 |
0.11 |
chr6_100732315_100732977 | 7.70 |
Gm15576 |
predicted gene 15576 |
6412 |
0.18 |
chr10_8233633_8233789 | 7.69 |
Gm30906 |
predicted gene, 30906 |
57580 |
0.14 |
chr5_92493499_92493715 | 7.69 |
Scarb2 |
scavenger receptor class B, member 2 |
12030 |
0.15 |
chr7_142550982_142551218 | 7.68 |
Nctc1 |
non-coding transcript 1 |
7496 |
0.1 |
chr4_128697865_128698491 | 7.62 |
Phc2 |
polyhomeotic 2 |
9383 |
0.19 |
chr9_80258670_80258821 | 7.62 |
Myo6 |
myosin VI |
3302 |
0.27 |
chr4_57601160_57601332 | 7.60 |
Pakap |
paralemmin A kinase anchor protein |
32916 |
0.21 |
chr8_11753299_11753467 | 7.57 |
Arhgef7 |
Rho guanine nucleotide exchange factor (GEF7) |
4934 |
0.13 |
chr1_189619376_189619727 | 7.55 |
Gm38122 |
predicted gene, 38122 |
20683 |
0.19 |
chr11_116285777_116286152 | 7.54 |
AL645861.1 |
zinc activated ion channel (ZACN) pseudogene |
406 |
0.7 |
chr1_57905961_57906300 | 7.54 |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
4059 |
0.23 |
chr9_35045693_35046412 | 7.53 |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
9742 |
0.18 |
chr8_115929769_115930140 | 7.52 |
Gm45733 |
predicted gene 45733 |
42117 |
0.21 |
chr1_193087008_193087448 | 7.51 |
Utp25 |
UTP25 small subunit processome component |
27447 |
0.12 |
chr5_92323289_92323584 | 7.46 |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
4642 |
0.11 |
chr5_119776458_119776795 | 7.46 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
31041 |
0.14 |
chr14_21669603_21670052 | 7.46 |
Dupd1 |
dual specificity phosphatase and pro isomerase domain containing 1 |
33275 |
0.14 |
chr8_114956612_114956825 | 7.46 |
Gm22556 |
predicted gene, 22556 |
96195 |
0.09 |
chr4_150809363_150809664 | 7.45 |
Gm13049 |
predicted gene 13049 |
16220 |
0.16 |
chr11_43914639_43914823 | 7.42 |
Adra1b |
adrenergic receptor, alpha 1b |
13521 |
0.24 |
chr13_37918976_37919130 | 7.41 |
Rreb1 |
ras responsive element binding protein 1 |
27963 |
0.17 |
chr2_35273634_35273923 | 7.38 |
Gm43128 |
predicted gene 43128 |
6612 |
0.15 |
chr9_25175025_25175376 | 7.37 |
Gm29642 |
predicted gene 29642 |
23086 |
0.14 |
chr9_59339210_59339361 | 7.35 |
Bbs4 |
Bardet-Biedl syndrome 4 (human) |
11772 |
0.19 |
chr14_25200807_25201012 | 7.29 |
4930572O13Rik |
RIKEN cDNA 4930572O13 gene |
57668 |
0.11 |
chr5_106989313_106989464 | 7.25 |
Cdc7 |
cell division cycle 7 (S. cerevisiae) |
14150 |
0.19 |
chr18_77505013_77505403 | 7.22 |
Rnf165 |
ring finger protein 165 |
90 |
0.97 |
chr11_59960852_59961150 | 7.20 |
Rasd1 |
RAS, dexamethasone-induced 1 |
3943 |
0.14 |
chr7_73716141_73716768 | 7.17 |
Gm45007 |
predicted gene 45007 |
9914 |
0.1 |
chr9_115243693_115243977 | 7.15 |
Stmn1-rs1 |
stathmin 1, related sequence 1 |
38146 |
0.12 |
chr8_75089066_75089278 | 7.14 |
Hmox1 |
heme oxygenase 1 |
4449 |
0.15 |
chr11_118365234_118365408 | 7.11 |
Timp2 |
tissue inhibitor of metalloproteinase 2 |
9581 |
0.14 |
chr4_150080458_150080615 | 7.11 |
Gpr157 |
G protein-coupled receptor 157 |
6829 |
0.11 |
chr13_43005060_43005377 | 7.09 |
Gm15809 |
predicted gene 15809 |
6707 |
0.27 |
chr9_118694402_118694558 | 7.08 |
Itga9 |
integrin alpha 9 |
8645 |
0.24 |
chrX_73479798_73479957 | 7.03 |
Bgn |
biglycan |
3725 |
0.15 |
chr12_111743660_111743835 | 7.02 |
Gm15996 |
predicted gene 15996 |
11916 |
0.1 |
chr4_32179679_32180088 | 6.99 |
Gm11929 |
predicted gene 11929 |
27265 |
0.16 |
chr4_15213205_15213456 | 6.99 |
Tmem64 |
transmembrane protein 64 |
52501 |
0.13 |
chr16_29761764_29762470 | 6.97 |
Gm49636 |
predicted gene, 49636 |
7805 |
0.23 |
chr15_67301869_67302358 | 6.95 |
1700012I11Rik |
RIKEN cDNA 1700012I11 gene |
75344 |
0.12 |
chr6_92869192_92869375 | 6.93 |
Gm15737 |
predicted gene 15737 |
74 |
0.97 |
chr1_37505157_37505314 | 6.92 |
Mgat4a |
mannoside acetylglucosaminyltransferase 4, isoenzyme A |
6397 |
0.16 |
chr4_139179928_139180623 | 6.92 |
Gm16287 |
predicted gene 16287 |
380 |
0.82 |
chr3_116929054_116929302 | 6.92 |
Gm42892 |
predicted gene 42892 |
15152 |
0.13 |
chr18_39294512_39294758 | 6.88 |
Arhgap26 |
Rho GTPase activating protein 26 |
2150 |
0.33 |
chr18_46627081_46627419 | 6.86 |
Gm3734 |
predicted gene 3734 |
3557 |
0.19 |
chrX_48108710_48108951 | 6.81 |
Xpnpep2 |
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
89 |
0.97 |
chr12_99938473_99938641 | 6.81 |
Tdp1 |
tyrosyl-DNA phosphodiesterase 1 |
23091 |
0.12 |
chr6_86547859_86548409 | 6.77 |
1600020E01Rik |
RIKEN cDNA 1600020E01 gene |
153 |
0.91 |
chr9_62732677_62732861 | 6.77 |
Itga11 |
integrin alpha 11 |
54909 |
0.11 |
chr7_51300260_51300721 | 6.77 |
Gm45002 |
predicted gene 45002 |
94339 |
0.08 |
chr3_22948234_22948432 | 6.75 |
Gm36983 |
predicted gene, 36983 |
124086 |
0.06 |
chr5_121586798_121586977 | 6.74 |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
6693 |
0.1 |
chr5_35921961_35922337 | 6.73 |
H2af-ps |
H2A histone family, pseudogene |
4252 |
0.24 |
chr7_98899864_98900015 | 6.72 |
Gm45188 |
predicted gene 45188 |
4009 |
0.16 |
chr11_72389832_72390004 | 6.67 |
Mir6338 |
microRNA 6338 |
1162 |
0.37 |
chr9_121894585_121894736 | 6.67 |
Ackr2 |
atypical chemokine receptor 2 |
3695 |
0.11 |
chr6_61931753_61931922 | 6.66 |
Ccser1 |
coiled-coil serine rich 1 |
24852 |
0.23 |
chr17_12179256_12179781 | 6.66 |
Tdgf1-ps2 |
teratocarcinoma-derived growth factor, pseudogene 2 |
10403 |
0.19 |
chr10_59510732_59510932 | 6.66 |
Mcu |
mitochondrial calcium uniporter |
52672 |
0.12 |
chr9_98647639_98647791 | 6.66 |
Mrps22 |
mitochondrial ribosomal protein S22 |
46055 |
0.09 |
chr14_9315302_9315456 | 6.66 |
Gm48370 |
predicted gene, 48370 |
85245 |
0.1 |
chr5_64840081_64840553 | 6.64 |
Klf3 |
Kruppel-like factor 3 (basic) |
13508 |
0.15 |
chr6_112459412_112459772 | 6.62 |
Cav3 |
caveolin 3 |
87 |
0.97 |
chr14_104796436_104796832 | 6.60 |
D130009I18Rik |
RIKEN cDNA D130009I18 gene |
157490 |
0.04 |
chr11_53098819_53099002 | 6.60 |
Gm11186 |
predicted gene 11186 |
21146 |
0.23 |
chr2_163345083_163345234 | 6.59 |
Tox2 |
TOX high mobility group box family member 2 |
24780 |
0.15 |
chr2_103577911_103578100 | 6.58 |
Abtb2 |
ankyrin repeat and BTB (POZ) domain containing 2 |
11695 |
0.19 |
chr8_117176468_117176619 | 6.56 |
Gan |
giant axonal neuropathy |
18406 |
0.19 |
chr12_116111465_116111628 | 6.56 |
Vipr2 |
vasoactive intestinal peptide receptor 2 |
25801 |
0.1 |
chr15_11166017_11166168 | 6.56 |
Adamts12 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 12 |
101274 |
0.07 |
chr10_8297302_8297492 | 6.54 |
Ust |
uronyl-2-sulfotransferase |
4845 |
0.33 |
chr2_46187390_46187554 | 6.52 |
Gm23072 |
predicted gene, 23072 |
118864 |
0.06 |
chr4_58184913_58185294 | 6.51 |
Svep1 |
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
21493 |
0.25 |
chr7_142547688_142548437 | 6.51 |
Nctc1 |
non-coding transcript 1 |
10534 |
0.1 |
chr2_12221651_12222208 | 6.49 |
Itga8 |
integrin alpha 8 |
20535 |
0.21 |
chr9_47575200_47575351 | 6.49 |
Cadm1 |
cell adhesion molecule 1 |
44902 |
0.15 |
chr5_136270005_136270238 | 6.48 |
Gm16599 |
predicted gene, 16599 |
4875 |
0.16 |
chr16_4851348_4851524 | 6.48 |
4930562C15Rik |
RIKEN cDNA 4930562C15 gene |
6818 |
0.14 |
chr7_45191786_45192369 | 6.48 |
Ccdc155 |
coiled-coil domain containing 155 |
2011 |
0.1 |
chr2_103051987_103052301 | 6.47 |
Pdhx |
pyruvate dehydrogenase complex, component X |
21191 |
0.17 |
chr4_142221224_142221954 | 6.46 |
Kazn |
kazrin, periplakin interacting protein |
11383 |
0.22 |
chr18_66652347_66652646 | 6.44 |
Gm50161 |
predicted gene, 50161 |
17897 |
0.12 |
chr14_45009426_45009579 | 6.43 |
Gm17173 |
predicted gene 17173 |
2602 |
0.16 |
chr11_35428167_35428338 | 6.41 |
Gm12122 |
predicted gene 12122 |
78183 |
0.1 |
chr2_155032981_155033288 | 6.40 |
a |
nonagouti |
14481 |
0.14 |
chr5_151116580_151116731 | 6.40 |
Stard13 |
StAR-related lipid transfer (START) domain containing 13 |
7920 |
0.26 |
chr15_52967716_52968060 | 6.39 |
Ext1 |
exostosin glycosyltransferase 1 |
139980 |
0.05 |
chr2_72657193_72657358 | 6.38 |
Ak3l2-ps |
adenylate kinase 3-like 2, pseudogene |
23339 |
0.16 |
chr12_102324651_102324838 | 6.37 |
Rin3 |
Ras and Rab interactor 3 |
30001 |
0.18 |
chr5_113789227_113789902 | 6.36 |
Tmem119 |
transmembrane protein 119 |
10882 |
0.09 |
chr1_60735032_60735423 | 6.36 |
Cd28 |
CD28 antigen |
11131 |
0.12 |
chr3_121588840_121589464 | 6.35 |
A730020M07Rik |
RIKEN cDNA A730020M07 gene |
54215 |
0.09 |
chr13_60012406_60012801 | 6.34 |
A530065N20Rik |
RIKEN cDNA A530046M15 gene |
17108 |
0.16 |
chr6_53944951_53945261 | 6.33 |
Cpvl |
carboxypeptidase, vitellogenic-like |
33556 |
0.15 |
chr11_46026178_46026358 | 6.33 |
Gm12165 |
predicted gene 12165 |
10172 |
0.14 |
chr4_56879079_56879230 | 6.32 |
Ctnnal1 |
catenin (cadherin associated protein), alpha-like 1 |
13966 |
0.13 |
chr14_22759778_22760001 | 6.30 |
Gm7473 |
predicted gene 7473 |
15355 |
0.28 |
chr19_45652381_45652616 | 6.30 |
Fbxw4 |
F-box and WD-40 domain protein 4 |
7814 |
0.2 |
chr18_9819884_9820035 | 6.29 |
Gm50079 |
predicted gene, 50079 |
1175 |
0.41 |
chr4_40226105_40226406 | 6.28 |
Ddx58 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
2101 |
0.28 |
chr3_94650538_94650690 | 6.28 |
Gm10972 |
predicted gene 10972 |
7516 |
0.1 |
chr17_47821438_47821619 | 6.27 |
Mdfi |
MyoD family inhibitor |
11641 |
0.12 |
chr8_120046692_120046901 | 6.25 |
Gm15684 |
predicted gene 15684 |
1509 |
0.32 |
chr6_72976900_72977158 | 6.24 |
Gm18402 |
predicted gene, 18402 |
6033 |
0.16 |
chr1_182520209_182520613 | 6.23 |
Capn2 |
calpain 2 |
2803 |
0.2 |
chr9_75870829_75871198 | 6.23 |
Gm47723 |
predicted gene, 47723 |
5247 |
0.21 |
chr15_80936776_80936928 | 6.22 |
Mir5113 |
microRNA 5113 |
3187 |
0.17 |
chr6_42396047_42396236 | 6.21 |
Tas2r143 |
taste receptor, type 2, member 143 |
4097 |
0.11 |
chr19_5935370_5935551 | 6.21 |
Pola2 |
polymerase (DNA directed), alpha 2 |
7259 |
0.08 |
chr3_146009957_146010192 | 6.21 |
Syde2 |
synapse defective 1, Rho GTPase, homolog 2 (C. elegans) |
16403 |
0.15 |
chr5_112001700_112002600 | 6.20 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr5_35624856_35625033 | 6.20 |
Acox3 |
acyl-Coenzyme A oxidase 3, pristanoyl |
14845 |
0.14 |
chr1_184675628_184676155 | 6.19 |
Gm38358 |
predicted gene, 38358 |
19143 |
0.14 |
chr7_120732949_120733317 | 6.18 |
Mosmo |
modulator of smoothened |
4809 |
0.13 |
chr11_119209401_119210151 | 6.16 |
Gm11752 |
predicted gene 11752 |
10384 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 10.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
2.2 | 6.5 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
2.1 | 4.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.0 | 6.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.8 | 7.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.7 | 6.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.7 | 3.4 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.6 | 4.9 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.6 | 6.5 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.6 | 4.8 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.6 | 10.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.5 | 9.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.5 | 13.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.5 | 4.5 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
1.5 | 4.5 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.4 | 7.1 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
1.4 | 4.2 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.4 | 4.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.4 | 5.5 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
1.4 | 4.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.3 | 4.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.3 | 4.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.3 | 2.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.3 | 2.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.3 | 1.3 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
1.2 | 1.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
1.2 | 2.4 | GO:0003166 | bundle of His development(GO:0003166) |
1.2 | 3.6 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.2 | 3.6 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
1.2 | 4.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.2 | 3.5 | GO:0003032 | detection of oxygen(GO:0003032) |
1.1 | 5.7 | GO:0009115 | xanthine catabolic process(GO:0009115) |
1.1 | 4.5 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.1 | 3.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.1 | 1.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.1 | 1.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.1 | 1.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.1 | 2.2 | GO:0060594 | mammary gland specification(GO:0060594) |
1.1 | 4.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.0 | 5.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.0 | 3.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.0 | 2.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.0 | 3.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
1.0 | 3.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.0 | 6.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.0 | 3.0 | GO:0007525 | somatic muscle development(GO:0007525) |
1.0 | 3.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.0 | 2.0 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.0 | 7.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.0 | 3.9 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
1.0 | 5.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.9 | 0.9 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.9 | 3.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.9 | 2.7 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.9 | 1.8 | GO:1902075 | cellular response to salt(GO:1902075) |
0.9 | 0.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.9 | 1.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.9 | 8.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.9 | 3.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.9 | 2.6 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.9 | 1.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.9 | 2.6 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.8 | 2.5 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.8 | 6.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.8 | 5.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.8 | 2.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.8 | 2.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.8 | 3.2 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.8 | 1.6 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.8 | 2.4 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.8 | 4.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.8 | 2.4 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.8 | 5.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.8 | 3.1 | GO:0008228 | opsonization(GO:0008228) |
0.8 | 4.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.8 | 2.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 2.3 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.8 | 0.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.7 | 3.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.7 | 1.5 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.7 | 4.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.7 | 2.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.7 | 2.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.7 | 0.7 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.7 | 9.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.7 | 2.8 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.7 | 2.1 | GO:0070836 | caveola assembly(GO:0070836) |
0.7 | 3.5 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.7 | 9.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.7 | 3.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.7 | 0.7 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.7 | 3.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 2.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.7 | 4.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.7 | 2.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 6.2 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.7 | 4.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.7 | 6.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.7 | 4.1 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.7 | 1.3 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.7 | 3.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.7 | 0.7 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.7 | 2.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.7 | 2.7 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.7 | 2.0 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.7 | 2.7 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) |
0.7 | 6.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.7 | 4.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.7 | 2.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.7 | 2.0 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.7 | 2.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.7 | 4.6 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.7 | 3.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.6 | 1.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 0.6 | GO:0003195 | tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
0.6 | 4.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.6 | 0.6 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.6 | 1.3 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.6 | 1.3 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.6 | 3.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.6 | 5.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.6 | 0.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.6 | 3.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.6 | 9.4 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.6 | 1.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.6 | 4.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.6 | 11.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.6 | 4.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.6 | 3.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.6 | 1.8 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.6 | 1.8 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.6 | 1.8 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.6 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.6 | 1.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.6 | 0.6 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.6 | 1.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.6 | 4.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 5.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.6 | 1.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.6 | 1.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.6 | 2.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.6 | 1.2 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.6 | 1.7 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.6 | 5.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.6 | 4.0 | GO:0060426 | lung vasculature development(GO:0060426) |
0.6 | 2.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.6 | 2.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.6 | 1.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.6 | 0.6 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.6 | 2.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.6 | 0.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.6 | 0.6 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.6 | 0.6 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.6 | 3.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.6 | 2.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.6 | 3.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.6 | 2.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.6 | 1.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.5 | 3.8 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.5 | 0.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.5 | 1.6 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 1.6 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.5 | 1.6 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.5 | 0.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.5 | 1.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 1.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.5 | 0.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.5 | 1.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.5 | 8.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.5 | 1.6 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.5 | 3.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 1.6 | GO:0015755 | fructose transport(GO:0015755) |
0.5 | 1.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 5.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.5 | 1.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.5 | 3.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.5 | 0.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.5 | 1.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.5 | 2.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.5 | 2.5 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.5 | 1.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.5 | 0.5 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.5 | 2.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.5 | 1.5 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.5 | 1.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.5 | 1.0 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.5 | 5.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 4.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.5 | 1.0 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.5 | 0.5 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.5 | 1.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.5 | 1.5 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.5 | 9.9 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.5 | 1.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 2.5 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.5 | 1.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 2.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.5 | 0.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.5 | 0.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.5 | 2.5 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.5 | 1.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.5 | 1.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.5 | 0.5 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) dorsal root ganglion development(GO:1990791) |
0.5 | 1.0 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.5 | 3.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 4.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.5 | 1.0 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.5 | 1.4 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.5 | 1.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.5 | 1.9 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.5 | 1.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 3.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.5 | 0.5 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.5 | 0.5 | GO:0018214 | protein carboxylation(GO:0018214) |
0.5 | 0.9 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.5 | 0.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.5 | 1.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 0.5 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.5 | 1.9 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.5 | 0.9 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.5 | 0.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.5 | 2.8 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 4.6 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.5 | 1.4 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.5 | 0.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.5 | 1.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.5 | 0.5 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.5 | 0.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.5 | 1.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.5 | 4.1 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.5 | 1.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.5 | 3.6 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
0.4 | 1.8 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 1.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 0.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.4 | 2.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.4 | 7.1 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.4 | 1.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.4 | 1.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.4 | 0.9 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.4 | 1.8 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.4 | 4.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.4 | 1.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.4 | 2.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 0.9 | GO:0002432 | granuloma formation(GO:0002432) |
0.4 | 1.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 1.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.4 | 0.4 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.4 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.4 | 4.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.4 | 1.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.4 | 2.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.4 | 2.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.4 | 4.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.4 | 5.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 1.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.4 | 1.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.4 | 1.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 1.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.4 | 7.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.4 | 0.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 0.4 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.4 | 1.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.4 | 0.8 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.4 | 1.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.4 | 0.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.4 | 0.4 | GO:0032741 | regulation of interleukin-18 production(GO:0032661) positive regulation of interleukin-18 production(GO:0032741) |
0.4 | 1.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 0.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 2.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.4 | 0.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.4 | 0.4 | GO:0010159 | specification of organ position(GO:0010159) |
0.4 | 2.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 1.2 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.4 | 0.8 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 0.8 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 0.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 1.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.4 | 1.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.4 | 0.8 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 0.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.4 | 0.8 | GO:0001555 | oocyte growth(GO:0001555) |
0.4 | 0.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.4 | 1.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 1.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 0.4 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.4 | 0.4 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.4 | 2.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.4 | 1.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.4 | 1.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.4 | 1.2 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 1.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 0.8 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.4 | 1.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.4 | 1.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.4 | 1.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.4 | 1.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 1.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.4 | 0.7 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.4 | 1.9 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.4 | 0.4 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.4 | 0.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.4 | 1.1 | GO:0044026 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.4 | 1.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.4 | 2.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.4 | 1.5 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.4 | 0.4 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 1.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.4 | 1.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.4 | 2.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.4 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 1.8 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.4 | 0.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.4 | 0.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 0.4 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.4 | 1.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.4 | 0.4 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.4 | 0.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.4 | 0.7 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.4 | 0.4 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.4 | 1.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 3.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 0.4 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.4 | 0.7 | GO:0021569 | rhombomere 3 development(GO:0021569) rhombomere morphogenesis(GO:0021593) |
0.4 | 4.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 0.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 1.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 1.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 1.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 2.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 0.7 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.3 | 2.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 0.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 3.8 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.3 | 1.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.3 | 1.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 2.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 0.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 1.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 1.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 1.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.3 | 1.4 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 0.3 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 2.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 0.3 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.3 | 1.0 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 1.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 0.7 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.3 | 1.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 0.3 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 2.0 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 0.7 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.3 | 0.3 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 0.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 1.3 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.3 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 1.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 1.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 1.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 1.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 0.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.3 | 1.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 1.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.3 | 2.8 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.3 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 2.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 1.6 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.3 | 0.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.6 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.3 | 0.9 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 0.9 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.3 | 1.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 1.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 1.5 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.3 | 0.9 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 1.5 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 2.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 2.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.3 | 0.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.3 | 0.6 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.3 | 0.9 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.3 | 2.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.3 | 0.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 1.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.3 | 0.9 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.3 | 0.3 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.3 | 6.2 | GO:0042073 | intraciliary transport(GO:0042073) |
0.3 | 1.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 0.6 | GO:1901163 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
0.3 | 0.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 0.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 1.5 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 0.9 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.3 | 0.6 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) |
0.3 | 1.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 0.6 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.3 | 0.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 1.8 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.3 | 1.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 0.6 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.3 | 1.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 1.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.3 | 0.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.3 | 1.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 1.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 0.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 1.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 0.3 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.3 | 0.9 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.3 | 0.9 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.3 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.3 | 0.8 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 6.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.3 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 0.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 1.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 1.7 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 0.3 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
0.3 | 0.8 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.3 | 0.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 4.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.3 | 1.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 1.1 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 0.8 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.3 | 0.6 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.3 | 1.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 1.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 1.1 | GO:0009415 | response to water(GO:0009415) |
0.3 | 1.1 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.3 | 1.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 0.3 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.3 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.3 | 0.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.3 | 0.5 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.3 | 1.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.3 | 2.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 0.5 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.3 | 0.8 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.3 | 0.3 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.3 | 0.5 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.3 | 0.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.3 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 0.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 0.8 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.3 | 0.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 1.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 0.8 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 1.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.3 | 0.3 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 0.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.3 | 0.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.3 | 0.5 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 0.5 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.3 | 0.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.3 | 2.9 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.3 | 0.3 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.3 | 1.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 3.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.3 | 1.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 1.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 0.5 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.3 | 0.5 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.3 | 1.8 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 0.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 0.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.3 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.8 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 0.8 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 1.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.3 | 0.8 | GO:0010042 | response to manganese ion(GO:0010042) |
0.3 | 0.8 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 0.8 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.3 | 0.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.3 | 0.5 | GO:0060268 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.3 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.3 | 0.8 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 0.5 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 4.7 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 1.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 0.7 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.5 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 0.2 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.2 | 0.5 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 6.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.2 | 0.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 0.5 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.2 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 2.2 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 1.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 4.8 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.2 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.2 | 0.7 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.2 | 0.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 1.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 1.7 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.2 | 0.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 1.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.5 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.5 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.2 | 2.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 3.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.7 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 7.6 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 0.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 3.3 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.2 | 0.2 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.2 | 0.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 0.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.2 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.2 | 0.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 0.5 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.5 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.2 | 1.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 2.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.2 | 0.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 0.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 1.4 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.2 | 0.7 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.2 | 0.9 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 0.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 3.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.2 | 1.8 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.2 | 0.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 1.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 0.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 0.7 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.2 | 0.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 1.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 2.8 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.2 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 1.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.2 | 0.4 | GO:0046078 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
0.2 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 2.3 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.2 | 1.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.4 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 4.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 2.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 0.2 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.2 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 4.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.2 | 0.4 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.8 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.2 | 1.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 1.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 2.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 3.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.8 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.2 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 0.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 4.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.6 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.2 | 0.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 0.8 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 0.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 1.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 1.0 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.2 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 0.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 0.8 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 0.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 1.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.2 | 0.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.2 | 1.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 0.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 2.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 0.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.2 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.2 | 0.4 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.2 | 1.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.6 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 4.2 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.2 | 0.6 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.2 | 0.2 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.2 | 1.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.2 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.2 | 0.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.8 | GO:0061009 | common bile duct development(GO:0061009) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.2 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.2 | 0.9 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.2 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.8 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.2 | 0.2 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 0.2 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.2 | 1.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.7 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.2 | 0.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 0.4 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.2 | 0.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.2 | 0.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.7 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 1.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 6.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.2 | 0.2 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.2 | 0.2 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.9 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 6.8 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 0.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 2.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.2 | 1.8 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.2 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 0.4 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.2 | 1.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 1.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.2 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.2 | 0.2 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.2 | 1.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.5 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 0.4 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.5 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 2.1 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.2 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.2 | 3.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 0.8 | GO:1901890 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) |
0.2 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 2.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.2 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.2 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 0.5 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.2 | 0.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 1.0 | GO:0036035 | osteoclast development(GO:0036035) |
0.2 | 4.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.2 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.2 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.7 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 0.5 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.7 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.2 | 0.2 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 0.3 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 3.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 3.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.2 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.2 | 0.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 1.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 4.4 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.2 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.2 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.2 | 0.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 13.4 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.2 | 1.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.8 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 0.3 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.2 | 0.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.5 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.2 | 0.5 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 1.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.2 | 0.8 | GO:0045078 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 0.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.2 | 2.0 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.2 | 0.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 1.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 2.8 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.2 | 0.5 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.2 | 2.5 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.2 | 0.3 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.2 | 0.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 2.8 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.2 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.5 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 0.5 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.9 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.8 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.2 | 0.5 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 0.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.2 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.2 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 1.0 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 1.8 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 1.3 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.9 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.4 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.7 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 1.6 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 1.0 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 1.9 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 1.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.7 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.1 | 0.1 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.1 | 2.7 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 1.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.4 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.3 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 1.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.1 | GO:0032205 | negative regulation of telomere maintenance(GO:0032205) |
0.1 | 0.3 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 1.7 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 1.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.8 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 3.2 | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway(GO:2001237) |
0.1 | 0.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 1.1 | GO:0034397 | telomere localization(GO:0034397) |
0.1 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.4 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 1.2 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.1 | 0.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.7 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.1 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.6 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.1 | 0.3 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.4 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 1.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 2.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.4 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.4 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.1 | 0.5 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.8 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0085020 | protein K27-linked ubiquitination(GO:0044314) protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.6 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.1 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 2.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 1.7 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.6 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.1 | 0.4 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.5 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 1.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 1.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.8 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.8 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 1.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.2 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.1 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.2 | GO:0015846 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.1 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.8 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 3.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.3 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.1 | 0.3 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.1 | 0.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 1.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.6 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.4 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 0.7 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.6 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.1 | 1.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.6 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 1.3 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.4 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.2 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 1.2 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.4 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:1904714 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.1 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.1 | 0.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.3 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.1 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 1.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 2.7 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 7.3 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.2 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.7 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 1.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.4 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.5 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.6 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.3 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 4.5 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 1.0 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 1.1 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.1 | 1.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.3 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 1.6 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.3 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 1.2 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.4 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.5 | GO:0032366 | intracellular lipid transport(GO:0032365) intracellular sterol transport(GO:0032366) |
0.1 | 1.0 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 1.6 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.1 | 0.2 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.3 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 2.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.2 | GO:0070589 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.2 | GO:0060603 | mammary gland duct morphogenesis(GO:0060603) |
0.1 | 1.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.9 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.1 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 0.9 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.4 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.1 | 0.2 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.2 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.5 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 2.4 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 0.8 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.2 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.5 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.3 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.1 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 0.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 1.0 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.1 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 0.3 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.1 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.4 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.3 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.1 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.2 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.3 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.1 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.1 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.5 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.1 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.1 | GO:0046070 | dGTP catabolic process(GO:0006203) dGTP metabolic process(GO:0046070) |
0.1 | 0.1 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 1.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.1 | GO:0000279 | M phase(GO:0000279) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 1.5 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.3 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.1 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 1.0 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.4 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.1 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
0.1 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.8 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.1 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.1 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 1.0 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.1 | 0.2 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.1 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.8 | GO:0001936 | regulation of endothelial cell proliferation(GO:0001936) |
0.1 | 0.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 1.1 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.1 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of hypersensitivity(GO:0002884) |
0.1 | 0.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.3 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
0.0 | 0.5 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.6 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.1 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.0 | 0.4 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.0 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.0 | 0.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.0 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.3 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.0 | 0.0 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.5 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 1.1 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 4.8 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.0 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.0 | 1.1 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.4 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.0 | 0.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.0 | 0.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.9 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:0072672 | cytokine secretion involved in immune response(GO:0002374) neutrophil extravasation(GO:0072672) |
0.0 | 0.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 1.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.5 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.0 | GO:0014831 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.2 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.0 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.0 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.1 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.2 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.0 | 0.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.1 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.0 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.0 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.2 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.0 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.0 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.1 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.0 | 0.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.0 | GO:0060157 | urea transport(GO:0015840) urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.0 | GO:0033079 | immature T cell proliferation(GO:0033079) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:0002883 | regulation of hypersensitivity(GO:0002883) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.0 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.2 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 18.3 | GO:0005861 | troponin complex(GO:0005861) |
1.9 | 5.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.8 | 5.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.5 | 6.0 | GO:0071953 | elastic fiber(GO:0071953) |
1.5 | 4.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.4 | 4.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.2 | 3.7 | GO:0097413 | Lewy body(GO:0097413) |
1.1 | 5.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.1 | 4.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.1 | 6.6 | GO:0030056 | hemidesmosome(GO:0030056) |
1.1 | 3.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.1 | 16.9 | GO:0031430 | M band(GO:0031430) |
1.0 | 4.0 | GO:0035363 | histone locus body(GO:0035363) |
0.9 | 2.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.9 | 15.1 | GO:0002102 | podosome(GO:0002102) |
0.8 | 2.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.8 | 11.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.8 | 9.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.7 | 3.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.7 | 2.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.7 | 3.5 | GO:0005638 | lamin filament(GO:0005638) |
0.7 | 2.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.7 | 5.3 | GO:0045179 | apical cortex(GO:0045179) |
0.7 | 4.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 1.9 | GO:0071942 | XPC complex(GO:0071942) |
0.6 | 8.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.6 | 1.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.6 | 1.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.6 | 0.6 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.6 | 2.5 | GO:0071203 | WASH complex(GO:0071203) |
0.6 | 2.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 1.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.6 | 3.4 | GO:0001652 | granular component(GO:0001652) |
0.6 | 4.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 2.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.5 | 26.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.5 | 0.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.5 | 1.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.5 | 1.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 8.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 1.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 3.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 4.9 | GO:0001527 | microfibril(GO:0001527) |
0.5 | 3.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.5 | 2.8 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 5.6 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.5 | 7.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.5 | 2.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 4.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 1.8 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.4 | 3.9 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 4.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 3.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 1.2 | GO:0005712 | chiasma(GO:0005712) |
0.4 | 1.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 10.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.4 | 2.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.4 | 4.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 1.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 1.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 4.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.4 | 3.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 3.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 4.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 1.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 1.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 4.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 1.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 3.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 3.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 0.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 5.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.4 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 1.0 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 0.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 3.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 4.4 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 19.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 1.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.3 | 2.2 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 2.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 0.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 1.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 3.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 11.1 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 1.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 8.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 5.3 | GO:0031672 | A band(GO:0031672) |
0.3 | 1.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 3.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 1.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 1.9 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 5.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 5.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 0.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 1.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 2.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 0.8 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 2.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 2.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 1.5 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 1.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 13.5 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 2.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 1.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 2.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.7 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 1.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 1.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 3.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 16.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 0.5 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 2.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 1.8 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 2.0 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 1.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 6.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 59.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 1.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 1.0 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 1.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 1.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 1.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 48.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 4.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 1.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 1.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 1.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 1.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 3.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 3.9 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 1.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 3.4 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 8.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 1.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.5 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 0.6 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 1.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 2.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 1.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 1.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.6 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.2 | 1.4 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 0.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 1.7 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 2.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 1.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 1.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 1.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 2.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 6.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.7 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 2.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 1.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.7 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 4.8 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 37.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 1.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.5 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 2.1 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 7.6 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 1.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.5 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 3.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 4.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 1.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 4.3 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 1.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 6.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 2.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 3.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.6 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 3.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.0 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 1.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 1.3 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.4 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 0.2 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 2.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 5.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 1.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 5.8 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.5 | GO:0097346 | INO80-type complex(GO:0097346) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.0 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 1.3 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 2.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.0 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.0 | 0.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.3 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.4 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.0 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 1.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 19.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.0 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.0 | GO:0071565 | nBAF complex(GO:0071565) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.5 | 7.6 | GO:0030172 | troponin C binding(GO:0030172) |
2.0 | 6.1 | GO:0031014 | troponin T binding(GO:0031014) |
1.8 | 12.9 | GO:0018632 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.8 | 5.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.8 | 5.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.7 | 8.3 | GO:0071253 | connexin binding(GO:0071253) |
1.6 | 4.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.6 | 4.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.4 | 1.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.4 | 4.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.4 | 4.2 | GO:0035939 | microsatellite binding(GO:0035939) |
1.3 | 4.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.2 | 3.7 | GO:0055100 | adiponectin binding(GO:0055100) |
1.2 | 3.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.2 | 3.5 | GO:0050692 | DBD domain binding(GO:0050692) |
1.2 | 14.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.1 | 5.7 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
1.1 | 5.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.1 | 4.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.1 | 4.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.0 | 7.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.9 | 4.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.9 | 8.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.9 | 7.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.9 | 2.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.8 | 5.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.8 | 2.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.8 | 2.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.8 | 2.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.8 | 2.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.8 | 2.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.7 | 4.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.7 | 0.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.7 | 4.4 | GO:0043814 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.7 | 0.7 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.7 | 2.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.7 | 2.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.7 | 2.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.7 | 4.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.7 | 2.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.7 | 2.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.7 | 4.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 0.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.7 | 1.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.7 | 2.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.7 | 2.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.7 | 1.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.7 | 6.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.7 | 0.7 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.7 | 2.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.7 | 2.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.7 | 2.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.6 | 1.9 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.6 | 2.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.6 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 4.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.6 | 1.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.6 | 4.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 0.6 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.6 | 2.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.6 | 1.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 1.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 3.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.6 | 1.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.6 | 2.2 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.6 | 1.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.6 | 5.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 3.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 1.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.5 | 2.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 4.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 2.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.5 | 4.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 2.1 | GO:0044682 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.5 | 2.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.5 | 1.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 2.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.5 | 6.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.5 | 2.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 1.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 2.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 1.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.5 | 2.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 2.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.5 | 0.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.5 | 1.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 1.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.5 | 1.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 1.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 1.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 1.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 3.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.4 | 1.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 7.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.4 | 1.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 4.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.4 | 21.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.4 | 1.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 8.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 1.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.4 | 1.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.4 | 2.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 5.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.4 | 0.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 2.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 2.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 1.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 4.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 4.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 6.0 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 1.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 1.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 7.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.4 | 1.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 3.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 6.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 1.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.4 | 3.1 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 1.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.4 | 2.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 0.8 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.4 | 3.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 2.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.4 | 1.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.4 | 4.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 1.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.4 | 5.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 1.5 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 1.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 0.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.4 | 2.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 2.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 2.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 1.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.4 | 1.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.4 | 0.4 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.4 | 2.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.4 | 2.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.4 | 1.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 1.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 3.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.3 | 5.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 1.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 2.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 1.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 4.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 1.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 1.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 1.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 2.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 3.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.3 | 1.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 1.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 3.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 1.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 1.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 1.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 1.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 2.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 0.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 0.9 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 1.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 0.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 0.9 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 0.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.3 | 3.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 2.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 2.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 0.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.3 | 1.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 3.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 0.9 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 2.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 1.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 1.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 0.8 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 7.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 3.0 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 0.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 0.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 1.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 1.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 0.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 2.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 0.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 1.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 0.5 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.3 | 0.3 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.3 | 0.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 1.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 1.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 6.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.3 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.2 | 4.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 3.9 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 0.7 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 2.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 1.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 9.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 8.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.7 | GO:0018574 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 1.2 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 1.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 3.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 1.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 1.6 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 7.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 0.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 2.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 0.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.2 | 1.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 2.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 1.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 1.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 2.0 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 1.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 5.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.8 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 2.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 0.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.9 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 1.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 2.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.2 | 10.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 2.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.6 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 1.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 10.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 1.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 2.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 12.7 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 2.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 1.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 3.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 0.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 1.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 2.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.2 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 1.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 1.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 1.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 1.7 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 2.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 0.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 2.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 1.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 2.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 3.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 1.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 1.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 2.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 2.1 | GO:0052790 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.2 | 3.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 0.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 0.8 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 0.7 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 2.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.9 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 1.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 0.5 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 3.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.5 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 8.0 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 0.6 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 1.2 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 1.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 4.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 1.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 1.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 0.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.6 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 3.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.3 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 12.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.0 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 3.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 4.8 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 2.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.3 | GO:0016530 | metallochaperone activity(GO:0016530) copper-dependent protein binding(GO:0032767) |
0.1 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.7 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 1.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 6.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 36.6 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.8 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 1.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 2.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.5 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 2.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.8 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.8 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 1.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 1.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) flap endonuclease activity(GO:0048256) |
0.1 | 1.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 4.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.9 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.1 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 3.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 9.0 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 1.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.8 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 1.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.4 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.8 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 1.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 10.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.2 | GO:0032557 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 2.1 | GO:0043914 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 1.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 1.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.7 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.6 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 1.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 1.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.2 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 1.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.6 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 2.8 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 1.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 3.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 4.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 1.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 1.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 1.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 2.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 7.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 2.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 3.5 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 23.2 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.9 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.8 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.2 | GO:0003918 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 15.1 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.1 | 0.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.1 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 1.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.0 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.0 | 0.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 3.4 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.1 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.0 | 0.0 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 7.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 1.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.0 | 5.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 1.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 1.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.0 | 0.0 | GO:0042887 | urea transmembrane transporter activity(GO:0015204) amide transmembrane transporter activity(GO:0042887) |
0.0 | 2.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 1.0 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.0 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 3.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.2 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 1.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.0 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 2.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.3 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.0 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.0 | 0.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.7 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.0 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.4 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.0 | GO:0039706 | co-receptor binding(GO:0039706) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 2.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.0 | 2.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.8 | 34.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.6 | 7.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 14.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 8.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.6 | 2.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.6 | 15.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 8.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 23.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 3.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.5 | 1.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 12.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 1.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.4 | 10.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 10.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 2.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 16.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 9.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.4 | 12.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 14.1 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 11.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 19.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 5.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 1.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 3.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 9.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 11.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 5.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 7.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 2.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 2.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 3.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 4.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 8.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 10.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 6.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 2.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 0.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 1.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 5.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 7.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 2.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 30.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 1.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 5.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 1.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 2.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 2.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 1.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 1.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 22.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 3.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 1.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 1.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 31.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 1.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 3.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 6.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 3.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 2.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 3.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 3.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 2.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 7.5 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 24.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.7 | 8.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 9.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.7 | 7.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.6 | 7.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.6 | 33.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 6.8 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.6 | 7.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 12.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.5 | 8.9 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.5 | 9.6 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.4 | 1.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 3.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 2.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 4.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 3.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 8.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.4 | 1.9 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.4 | 3.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 4.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 3.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 2.7 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 3.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 2.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 3.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 3.7 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.3 | 5.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 6.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 3.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 1.6 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.3 | 2.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 6.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 5.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 5.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 2.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 3.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 4.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 2.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.3 | 4.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 1.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 0.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 3.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 1.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 1.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 0.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.3 | 1.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 2.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 26.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 12.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 1.7 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 1.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 3.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 8.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 6.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 2.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 6.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 4.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 2.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 1.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 1.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 1.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 2.2 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 2.8 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.2 | 1.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 0.2 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 1.6 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 1.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 4.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 3.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 2.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 0.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 2.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 2.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 1.3 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 4.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 4.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 0.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 1.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 13.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 5.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 3.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 2.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 5.9 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 7.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 3.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 3.0 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 4.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.1 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 1.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 4.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 4.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 2.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 2.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 3.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.3 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
0.1 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.8 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 10.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.1 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.0 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.0 | 1.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 1.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 1.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 5.5 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 1.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.5 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 1.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |